Tag: report

Results from the Phase 2 RedirecTT-1 study demonstrate deep responses with 78.9 percent overall response rate through dual targeting of GPRC5D and BCMA¹ 

HAMPTON, N.J., June 14, 2025 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced data demonstrating that barzolvolimab profoundly improves angioedema at 52 weeks in the Company’s Phase 2 clinical trial in chronic spontaneous urticaria (CSU). Angioedema, characterized by swelling of the deeper dermal layers of the skin and mucous membranes, is a painful, debilitating symptom of CSU that has significant impact on quality of life. It commonly affects the face (lips and eyelids), hands, feet, and genitalia but can also involve the tongue, uvula, soft palate, and pharynx¹.

Washington D.C., June 14, 2025 (GLOBE NEWSWIRE) -- You can find the article here:  https://thinkcarebelieve.blog/2025/06/14/week-21-of-americas-progress-under-president-trump/

11 of 12 participants (92%) enrolled in the 180mg cohort achieved a complete response

HONG KONG, June 14, 2025 (GLOBE NEWSWIRE) -- GA (Int’l) Capital Management Limited confirms that the Securities and Futures Commission (SFC) of Hong Kong issued a temporary restriction notice on June 6 2025, pursuant to Sections 204 and 205 of the Securities and Futures Ordinance (SFO). This action follows an incident involving a mainland China-registered corporate client who submitted fraudulent tax documentation during compliance onboarding.